Results 301 to 310 of about 204,272 (330)
Some of the next articles are maybe not open access.
Angiotensin-Converting Enzyme (ACE) Inhibitors
2015Angiotensin converting enzyme inhibitors represent a new class of agents which were designed to retain only that unique property. Because of this inhibition, administration of these agents results in the significant reduction of elevated blood pressure of various etiologies and in the amelioration of symptoms associated with congestive heart failure ...
Daniel Thomas Ginat, Jason M. Johnson
openaire +2 more sources
Oral angiotensin-converting-enzyme inhibitors
American Journal of Health-System Pharmacy, 1997The pharmacology, pharmacokinetics, clinical uses, adverse effects, drug interactions, dosage, cost, and therapeutic interchange of oral angiotension-converting-enzyme (ACE) inhibitors are reviewed. ACE inhibitors attenuate the formation of angiotension II and may lead to the accumulation of kinins.
openaire +2 more sources
2 Inhibitiors of Angiotensin-Converting Enzyme
1980Publisher Summary This chapter focuses on the development, mechanism of action, and biological activity of two distinct classes of therapeutically useful inhibitors of angiotensin-converting enzyme: the snake venom peptides and a newly developed class of orally active inhibitors that were designed for specific binding to the active site of this ...
David W. Cushman, Miguel A. Ondetti
openaire +3 more sources
Angiotensin converting enzyme inhibitors in pregnancy
Seminars in Perinatology, 1997Angiotensin converting enzyme (ACE) inhibitors are excellent antihypertensive agents and are becoming widely used as first-line therapy for chronic hypertension in women of reproductive age owing to their efficacy and few side effects. Reports of adverse fetal and neonatal effects from the use of ACE inhibitors in pregnancy in both animal and human ...
openaire +3 more sources
Overview of the angiotensin-converting-enzyme inhibitors
American Journal of Health-System Pharmacy, 2000The pharmacology of angiotensin-converting-enzyme (ACE) inhibitors and their role in the renin-angiotensin system (RAS) are described, and pharmacokinetic properties and common adverse events are presented. ACE inhibitors play a vital role in the RAS by regulating the potent vasoconstrictor angiotensin II.
openaire +3 more sources
Angiotensin‐Converting enzyme inhibitors
Medical Journal of Australia, 1994openaire +6 more sources
Angiotensin-converting enzyme inhibitors
Journal of the American Academy of Dermatology, 1993Anil Abraham, Eugene M. Farber
openaire +4 more sources